Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod vs Interferon Beta-1b for Cognitive Symptoms in RRMS
NCT01333501Phase 4Completed
- Sponsor
- Novartis
- Start
- May 2011
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of fingolimod in relapsing-remitting multiple sclerosis (RRMS), sponsored by Novartis. Started May 2011; status: completed.
02
Drugs
fingolimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01333501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333501.